ASX - By Stock
|
KZA |
Re:
Ann: Kazia Annual Report to shareholders
|
|
Gofish1
|
26 |
7.4K |
5 |
27/08/20 |
27/08/20 |
ASX - By Stock
|
26
|
7.4K
|
5
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia Annual Report to shareholders
|
|
Gofish1
|
26 |
7.4K |
2 |
27/08/20 |
27/08/20 |
ASX - By Stock
|
26
|
7.4K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
Gofish1
|
2.0K |
622K |
2 |
26/08/20 |
26/08/20 |
ASX - By Stock
|
2.0K
|
622K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia's paxalisib awarded Orphan Drug Designation
|
|
Gofish1
|
19 |
7.8K |
5 |
24/08/20 |
24/08/20 |
ASX - By Stock
|
19
|
7.8K
|
5
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia's paxalisib awarded Orphan Drug Designation
|
|
Gofish1
|
19 |
7.8K |
10 |
24/08/20 |
24/08/20 |
ASX - By Stock
|
19
|
7.8K
|
10
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia's paxalisib granted Fast Track Designation by FDA
|
|
Gofish1
|
66 |
21K |
11 |
22/08/20 |
22/08/20 |
ASX - By Stock
|
66
|
21K
|
11
|
|
ASX - By Stock
|
KZA |
Re:
Alliance A071701: Genomically guided treatment trial in brain metastases.
|
|
Gofish1
|
40 |
12K |
12 |
16/08/20 |
16/08/20 |
ASX - By Stock
|
40
|
12K
|
12
|
|
ASX - By Stock
|
KZA |
Re:
Across the pond...Nasdaq: KZIA
|
|
Gofish1
|
270 |
75K |
5 |
13/08/20 |
13/08/20 |
ASX - By Stock
|
270
|
75K
|
5
|
|
ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
Gofish1
|
2.0K |
622K |
2 |
12/08/20 |
12/08/20 |
ASX - By Stock
|
2.0K
|
622K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
Kza
|
|
Gofish1
|
73 |
22K |
1 |
10/08/20 |
10/08/20 |
ASX - By Stock
|
73
|
22K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
Across the pond...Nasdaq: KZIA
|
|
Gofish1
|
270 |
75K |
3 |
08/08/20 |
08/08/20 |
ASX - By Stock
|
270
|
75K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
Across the pond...Nasdaq: KZIA
|
|
Gofish1
|
270 |
75K |
6 |
08/08/20 |
08/08/20 |
ASX - By Stock
|
270
|
75K
|
6
|
|
ASX - By Stock
|
KZA |
Re:
Across the pond...Nasdaq: KZIA
|
|
Gofish1
|
270 |
75K |
2 |
08/08/20 |
08/08/20 |
ASX - By Stock
|
270
|
75K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia's paxalisib obtains Rare Pediatric Disease Designation
|
|
Gofish1
|
102 |
33K |
3 |
07/08/20 |
07/08/20 |
ASX - By Stock
|
102
|
33K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
News: KZA Kazia Therapeutics Says U.S. FDA Grants Rare Pediatric Disease Designation To Paxalisib
|
|
Gofish1
|
29 |
10K |
1 |
07/08/20 |
07/08/20 |
ASX - By Stock
|
29
|
10K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
Gofish1
|
2.0K |
622K |
0 |
29/07/20 |
29/07/20 |
ASX - By Stock
|
2.0K
|
622K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
Across the pond...Nasdaq: KZIA
|
|
Gofish1
|
270 |
75K |
1 |
27/07/20 |
27/07/20 |
ASX - By Stock
|
270
|
75K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
Gofish1
|
2.0K |
622K |
2 |
25/07/20 |
25/07/20 |
ASX - By Stock
|
2.0K
|
622K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
Gofish1
|
2.0K |
622K |
4 |
25/07/20 |
25/07/20 |
ASX - By Stock
|
2.0K
|
622K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Ceasing to be a substantial holder
|
|
Gofish1
|
67 |
14K |
6 |
24/07/20 |
24/07/20 |
ASX - By Stock
|
67
|
14K
|
6
|
|
ASX - By Stock
|
KZA |
Re:
Across the pond...Nasdaq: KZIA
|
|
Gofish1
|
270 |
75K |
1 |
16/07/20 |
16/07/20 |
ASX - By Stock
|
270
|
75K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
Across the pond...Nasdaq: KZIA
|
|
Gofish1
|
270 |
75K |
1 |
16/07/20 |
16/07/20 |
ASX - By Stock
|
270
|
75K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
Gofish1
|
2.0K |
622K |
3 |
16/07/20 |
16/07/20 |
ASX - By Stock
|
2.0K
|
622K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
For MEIP holders.
|
|
Gofish1
|
39 |
19K |
0 |
08/07/20 |
08/07/20 |
ASX - By Stock
|
39
|
19K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
SNO August Brain Mets Conf
|
|
Gofish1
|
17 |
5.7K |
0 |
03/07/20 |
03/07/20 |
ASX - By Stock
|
17
|
5.7K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia presents to Hidden Gems ********* Investor Webinar
|
|
Gofish1
|
17 |
4.3K |
0 |
26/06/20 |
26/06/20 |
ASX - By Stock
|
17
|
4.3K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
Gofish1
|
2.0K |
622K |
8 |
23/06/20 |
23/06/20 |
ASX - By Stock
|
2.0K
|
622K
|
8
|
|
ASX - By Stock
|
KZA |
Re:
In defence of James Garner
|
|
Gofish1
|
11 |
2.8K |
5 |
30/04/20 |
30/04/20 |
ASX - By Stock
|
11
|
2.8K
|
5
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia paxalisib Phase II interim data
|
|
Gofish1
|
25 |
7.8K |
4 |
09/04/20 |
09/04/20 |
ASX - By Stock
|
25
|
7.8K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia paxalisib Phase II interim data
|
|
Gofish1
|
25 |
7.8K |
8 |
09/04/20 |
09/04/20 |
ASX - By Stock
|
25
|
7.8K
|
8
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia joins GBM Agile
|
|
Gofish1
|
157 |
67K |
1 |
11/12/19 |
11/12/19 |
ASX - By Stock
|
157
|
67K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia joins GBM Agile
|
|
Gofish1
|
157 |
67K |
7 |
11/12/19 |
11/12/19 |
ASX - By Stock
|
157
|
67K
|
7
|
|
ASX - By Stock
|
KZA |
Re:
Value of Cantrixil
|
|
Gofish1
|
26 |
37K |
2 |
17/08/19 |
17/08/19 |
ASX - By Stock
|
26
|
37K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Novogen Presents at Biotech Showcase Conference
|
|
Gofish1
|
42 |
9.4K |
3 |
10/01/17 |
10/01/17 |
ASX - By Stock
|
42
|
9.4K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
Even Some Longs Dont Get It
|
|
Gofish1
|
10 |
3.5K |
4 |
19/12/16 |
19/12/16 |
ASX - By Stock
|
10
|
3.5K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
News article
|
|
Gofish1
|
16 |
6.0K |
4 |
10/12/16 |
10/12/16 |
ASX - By Stock
|
16
|
6.0K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
Trial start
|
|
Gofish1
|
33 |
8.7K |
2 |
06/12/16 |
06/12/16 |
ASX - By Stock
|
33
|
8.7K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
Trial start
|
|
Gofish1
|
33 |
8.7K |
3 |
06/12/16 |
06/12/16 |
ASX - By Stock
|
33
|
8.7K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
Ann: In-licencing of Phase II-ready molecule - presentation-NRT.AX
|
|
Gofish1
|
29 |
10K |
8 |
31/10/16 |
31/10/16 |
ASX - By Stock
|
29
|
10K
|
8
|
|
ASX - By Stock
|
KZA |
Re:
NRT will the real Novogen stand up please
|
|
Gofish1
|
135 |
32K |
5 |
23/08/16 |
23/08/16 |
ASX - By Stock
|
135
|
32K
|
5
|
|
ASX - By Stock
|
KZA |
Re:
NRT will the real Novogen stand up please
|
|
Gofish1
|
135 |
32K |
3 |
23/08/16 |
23/08/16 |
ASX - By Stock
|
135
|
32K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Novogen submits IND Application to the FDA for Cantrixil-NRT.AX
|
|
Gofish1
|
86 |
23K |
6 |
12/08/16 |
12/08/16 |
ASX - By Stock
|
86
|
23K
|
6
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Novogen submits IND Application to the FDA for Cantrixil-NRT.AX
|
|
Gofish1
|
86 |
23K |
2 |
11/08/16 |
11/08/16 |
ASX - By Stock
|
86
|
23K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
Sell, Sell, Sell.
|
|
Gofish1
|
35 |
9.5K |
0 |
19/07/16 |
19/07/16 |
ASX - By Stock
|
35
|
9.5K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
Please explain
|
|
Gofish1
|
14 |
3.4K |
4 |
02/07/16 |
02/07/16 |
ASX - By Stock
|
14
|
3.4K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
Holiday
|
|
Gofish1
|
49 |
13K |
4 |
14/06/16 |
14/06/16 |
ASX - By Stock
|
49
|
13K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
Holiday
|
|
Gofish1
|
49 |
13K |
4 |
30/05/16 |
30/05/16 |
ASX - By Stock
|
49
|
13K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Novogen provides Cantrixil update-NRT.AX
|
|
Gofish1
|
32 |
9.0K |
4 |
02/05/16 |
02/05/16 |
ASX - By Stock
|
32
|
9.0K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
Just to change topic
|
|
Gofish1
|
96 |
22K |
1 |
22/04/16 |
22/04/16 |
ASX - By Stock
|
96
|
22K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
Broker Data
|
|
Gofish1
|
97 |
26K |
2 |
23/03/16 |
23/03/16 |
ASX - By Stock
|
97
|
26K
|
2
|
|